Loading...
•
Sep 26, 2020
Thermo Fisher Q3 2020 Earnings Report
Thermo Fisher's Q3 2020 earnings significantly increased due to strong revenue growth and pandemic response.
Key Takeaways
Thermo Fisher Scientific reported a strong third quarter in 2020, with revenue increasing by 36% to $8.52 billion and adjusted EPS increasing by 91% to $5.63. The company benefited from $2.0 billion in COVID-19 related revenue and growth in its base business.
Revenue increased 36% to $8.52 billion.
GAAP diluted EPS increased 157% to $4.84.
Adjusted EPS increased 91% to $5.63.
Generated $2.0 billion of COVID-19 related revenue and returned the base business to growth.
Revenue by Segment
Forward Guidance
Thermo Fisher is on track to deliver a record year and is positioning the company for an even brighter future.
Positive Outlook
- Launching new products across the company.
- Scaling up production of sample collection products.
- Scaling up production of essential laboratory supplies.
- Increasing pharma services capacity to support new therapies and vaccines.
- Creating a strong foundation for future growth.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...